Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis. - Archive ouverte HAL Access content directly
Journal Articles BMC Psychiatry Year : 2011

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.

(1) , (2, 3) , (4) , (5) , (1) , (5) , (6)
1
2
3
4
5
6

Abstract

OBJECTIVE: To compare the rate of relapse as a function of antipsychotic treatment (monotherapy vs. polypharmacy) in schizophrenic patients over a 2-year period. METHODS: Using data from a multicenter cohort study conducted in France, we performed a propensity-adjusted analysis to examine the association between the rate of relapse over a 2-year period and antipsychotic treatment (monotherapy vs. polypharmacy). RESULTS: Our sample consisted in 183 patients; 50 patients (27.3%) had at least one period of relapse and 133 had no relapse (72.7%). Thirty-eight (37.7) percent of the patients received polypharmacy. The most severely ill patients were given polypharmacy: the age at onset of illness was lower in the polypharmacy group (p = 0.03). Patients that received polypharmacy also presented a higher general psychopathology PANSS subscore (p = 0.04) but no statistically significant difference was found in the PANSS total score or the PANSS positive or negative subscales. These patients were more likely to be given prescriptions for sedative drugs (p < 0.01) and antidepressant medications (p = 0.03). Relapse was found in 23.7% of patients given monotherapy and 33.3% given polypharmacy (p = 0.16). After stratification according to quintiles of the propensity score, which eliminated all significant differences for baseline characteristics, antipsychotic polypharmacy was not statistically associated with an increase of relapse: HR = 1.686 (0.812; 2.505). CONCLUSION: After propensity score adjustment, antipsychotic polypharmacy is not statistically associated to an increase of relapse. Future randomised studies are needed to assess the impact of antipsychotic polypharmacy in schizophrenia.
Fichier principal
Vignette du fichier
1471-244X-11-24.pdf (177.65 Ko) Télécharger le fichier
Vignette du fichier
1471-244X-11-24.xml (103.21 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00573378 , version 1 (03-03-2011)

Identifiers

Cite

Aurélie Millier, Emmanuelle Sarlon, Jean-Michel Azorin, Laurent Boyer, Samuel Aballea, et al.. Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.. BMC Psychiatry, 2011, 11 (1), pp.24. ⟨10.1186/1471-244X-11-24⟩. ⟨inserm-00573378⟩
99 View
177 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More